SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-000924
Filing Date
2021-08-05
Accepted
2021-08-05 16:02:49
Documents
68
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q spro-20210630.htm   iXBRL 10-Q 3131232
2 EX-10.1 spro-20210630ex10_1.htm EX-10.1 874724
3 EX-10.2 spro-20210630ex10_2.htm EX-10.2 166115
4 EX-31.1 spro-20210630ex31_1.htm EX-31.1 10959
5 EX-31.2 spro-20210630ex31_2.htm EX-31.2 10987
6 EX-32 spro-20210630ex32.htm EX-32 9631
7 GRAPHIC img110152170_0.jpg GRAPHIC 33898
  Complete submission text file 0000950170-21-000924.txt   11291496

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT spro-20210630.xsd EX-101.SCH 66564
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT spro-20210630_cal.xml EX-101.CAL 40555
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT spro-20210630_lab.xml EX-101.LAB 496185
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT spro-20210630_def.xml EX-101.DEF 241226
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT spro-20210630_pre.xml EX-101.PRE 376613
13 EXTRACTED XBRL INSTANCE DOCUMENT spro-20210630_htm.xml XML 1793841
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38266 | Film No.: 211148069
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences